Wednesday, February 10, 2010, 7:23pm SGT - The Singapore stock market is closed.
To create a watchlist or portfolio of shares, Register
FINANCE HOME PAGEINVESTINGFINANCE NEWS
    Market:       |  

SuperGen Inc. (SUPG)

At 5:00AM SGT: 2.82 USD   0.00 (0.00%)  
 MORE ON SUPG 
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
 SuperGen, Inc. (NGM:SUPG) Delayed quote dataEdit
Last Trade:2.82 USD
Trade Time:5:00AM SGT
Change: 0.00 (0.00%)
Prev Close:2.82
Open:N/A
Bid:2.47 x 1000
Ask:3.18 x 1000
1y Target Est:3.00
Day's Range:N/A - N/A
52wk Range:1.54 - 3.30
Volume:0
Avg Vol (3m):338,906
Market Cap:169.60M
P/E (ttm):N/A
EPS (ttm):-0.00
Div & Yield:N/A (N/A%)
[Chart]
1d  5d  3m  6m  1y  2y  5y  max 
Use Y! Toolbar to track stocks
 Add SUPG to Portfolio   Download Data

 HEADLINES 
•SuperGen to Present at BIO CEO & Investor Conference on February 8th
Business Wire (Mon, Feb 1)
•SUPERGEN INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Sat, Jan 23)
•SuperGen to Present at Biotech Showcase 2010 on January 12th
Business Wire (Tue, Jan 5)
•Today's 5-Star Movers
at Motley Fool (Sat, Dec 5)
•SuperGen Data Presentations at American Society of Hematology (ASH) Annual Meeting
Business Wire (Tue, Dec 1)
•SUPERGEN INC Financials
EDGAR Online Financials (Fri, Nov 13)
•SUPERGEN INC Files SEC form 10-Q, Quarterly Report
EDGAR Online (Tue, Nov 10)
•5-Star Stocks on the Upswing
at Motley Fool (Tue, Nov 3)
•SUPERGEN INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Unregistered Sale of Equity Securities,
EDGAR Online (Thu, Oct 29)
•SuperGen Earnings Call scheduled for 4:30 pm ET today
CCBN (Tue, Oct 27)
More Headlines for SUPG...
 ANALYST 
EPS Est (next year) (Dec-09) :0.03
EPS Est (in 2 years) (Dec-10) :-0.20
Avg Rec (current)*:2.0
PEG Ratio:N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

 BUSINESS SUMMARY 
SuperGen, Inc., a pharmaceutical company, engages in the discovery, development, and commercialization of therapies to treat patients with cancer. The company licensed its new drug application approved product, Dacogen for the treatment of patient...

Full Company Profile



Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Search by Company
•Latest News•Singapore Indices